NeuroPointDX Announces Confirmation of First-Generation Autism Diagnostic Panel
 /  News / NeuroPointDX Announces Confirmation of First-Generation Autism Diagnostic Panel

NeuroPointDX Announces Confirmation of First-Generation Autism Diagnostic Panel

NeuroPointDX has validated 12 metabolic subtypes of autism spectrum disorder. The diagnostic blood test for ASD will be available later this year.

CEO Elizabeth Donley says, “This is a historic moment, not just for Stemina and NeuroPointDX, but for our knowledge and understanding of autism.”

Read the full press release.

Related Posts

(608) 441-8187

504 S. Rosa Rd. Suite 150
Madison, WI 53719

contact@NeuroPointDx.com

FOLLOW US